<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<!--The publisher of this article does not allow downloading of the full text in XML form.-->
<?properties manuscript?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-journal-id">8508183</journal-id>
<journal-id journal-id-type="pubmed-jr-id">1289</journal-id>
<journal-id journal-id-type="nlm-ta">Pediatr Neurol</journal-id>
<journal-id journal-id-type="iso-abbrev">Pediatr. Neurol.</journal-id>
<journal-title-group>
<journal-title>Pediatric neurology</journal-title>
</journal-title-group>
<issn pub-type="ppub">0887-8994</issn>
<issn pub-type="epub">1873-5150</issn>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">30928302</article-id>
<article-id pub-id-type="pmc">7120929</article-id>
<article-id pub-id-type="doi">10.1016/j.pediatrneurol.2019.02.015</article-id>
<article-id pub-id-type="manuscript">NIHMS1525618</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Article</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Cyclin-dependent kinase-like 5 (CDKL5) deficiency disorder: clinical review</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Olson</surname>
<given-names>Heather E.</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Demarest</surname>
<given-names>Scott T.</given-names>
</name>
<xref ref-type="aff" rid="A2">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Pestana-Knight</surname>
<given-names>Elia M.</given-names>
</name>
<xref ref-type="aff" rid="A3">3</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Swanson</surname>
<given-names>Lindsay C.</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Iqbal</surname>
<given-names>Sumaiya</given-names>
</name>
<xref ref-type="aff" rid="A4">4</xref>
<xref ref-type="aff" rid="A5">5</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Lal</surname>
<given-names>Dennis</given-names>
</name>
<xref ref-type="aff" rid="A4">4</xref>
<xref ref-type="aff" rid="A6">6</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Leonard</surname>
<given-names>Helen</given-names>
</name>
<xref ref-type="aff" rid="A7">7</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Cross</surname>
<given-names>J. Helen</given-names>
</name>
<xref ref-type="aff" rid="A8">8</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Devinsky</surname>
<given-names>Orrin</given-names>
</name>
<xref ref-type="aff" rid="A9">9</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Benke</surname>
<given-names>Tim A.</given-names>
</name>
<xref ref-type="aff" rid="A10">10</xref>
</contrib>
</contrib-group>
<aff id="A1"><label>1</label>Department of Neurology, Division of Epilepsy and Clinical Neurophysiology, Boston Children’s Hospital, Boston, MA, USA</aff>
<aff id="A2"><label>2</label>Children’s Hospital Colorado and Department of Pediatrics, University of Colorado, School of Medicine, Aurora, CO, USA</aff>
<aff id="A3"><label>3</label>Cleveland Clinic Neurological Institute Epilepsy Center, Cleveland Clinic Neurological Institute Pediatric Neurology Department, Neurogenetics, Cleveland Clinic Children’s, Cleveland, OH.</aff>
<aff id="A4"><label>4</label>Stanley Center for Psychiatric Research, Broad Institute of MIT and Harvard, Cambridge, MA, USA</aff>
<aff id="A5"><label>5</label>Analytic and Translational Genetics Unit, Massachusetts General Hospital, Boston, MA, USA</aff>
<aff id="A6"><label>6</label>Cleveland Clinic Genomic Medicine Institute and Neurological Institute, Cleveland, OH, US</aff>
<aff id="A7"><label>7</label>Telethon Kids Institute, University of Western Australia, Perth, WA, Australia</aff>
<aff id="A8"><label>8</label>UCL Great Ormond Street NIHR BRC Institute of Child Health, London, UK</aff>
<aff id="A9"><label>9</label>Department of Neurology, NYU Langone Health, New York, NY</aff>
<aff id="A10"><label>10</label>Children’s Hospital Colorado and Departments of Pediatrics, Pharmacology, Neurology and Otolaryngology, University of Colorado, School of Medicine, Aurora, CO, USA</aff>
<author-notes>
<corresp id="CR1"><bold>Corresponding author:</bold> Heather Olson, MD, MS, Boston Children’s Hospital, 300 Longwood, Ave., Mailstop 3063, Boston, MA 02115, <email>Heather.Olson@childrens.harvard.edu</email></corresp>
</author-notes>
<pub-date pub-type="nihms-submitted">
<day>7</day>
<month>3</month>
<year>2020</year>
</pub-date>
<pub-date pub-type="epub">
<day>23</day>
<month>2</month>
<year>2019</year>
</pub-date>
<pub-date pub-type="ppub">
<month>8</month>
<year>2019</year>
</pub-date>
<pub-date pub-type="pmc-release">
<day>01</day>
<month>8</month>
<year>2020</year>
</pub-date>
<volume>97</volume>
<fpage>18</fpage>
<lpage>25</lpage>
<!--elocation-id from pubmed: 10.1016/j.pediatrneurol.2019.02.015-->
<abstract id="ABS1">
<p id="P1">CDKL5 deficiency disorder (CDD) is a developmental encephalopathy caused by pathogenic variants in the gene cyclin-dependent kinase-like 5 <italic>(CDKL5).</italic> This unique disorder includes early infantile onset refractory epilepsy, hypotonia, developmental intellectual and motor disabilities, and cortical visual impairment. We review the clinical presentations and genetic variations in CDD based on a systematic literature review and experience in the CDKL5 Centers of Excellence (COEs). We propose minimum diagnostic criteria. Pathogenic variants include deletions, truncations, splice variants, and missense variants. Pathogenic missense variants occur exclusively within the kinase domain or affect splice sites. The CDKL5 protein is widely expressed in the brain, predominantly in neurons, with roles in cell proliferation, neuronal migration, axonal outgrowth, dendritic morphogenesis and synapse development. The molecular biology of CDD is revealing opportunities in precision therapy, with phase 2 and 3 clinical trials underway or planned to assess disease specific and disease modifying treatments.</p>
</abstract>
<kwd-group>
<kwd>CDKL5 deficiency disorder</kwd>
<kwd>developmental encephalopathy</kwd>
<kwd>epileptic encephalopathy</kwd>
<kwd>epilepsy genetics</kwd>
<kwd>clinical trials</kwd>
</kwd-group>
</article-meta>
</front>
</article>
</pmc-articleset>